keyboard_arrow_up

Tumor Ablation Market worth $462.0 Million by 2019

The report “Tumor Ablation Market by Procedure Volume, technology (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis) - Global Forecasts to 2019”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

 

Browse 91 market data tables and 57 figures spread through 195 pages and in-depth TOC on “Tumor Ablation Market"
http://www.marketsandmarkets.com/Market-Reports/tumor-ablation-market-142550258.html
Early buyers will receive 10% customization on this report.

 

Based on the type of technology, the global tumor ablation market is classified into four major segments, namely radiofrequency, microwave, cryoablation, and other technologies (including irreversible electroporation, radio-iodine, HIFU, and laser ablation) segments. Moreover, based on type of departments, the global tumor ablation market is classified into three segments, namely, interventional radiology, surgery, and oncology. The global tumor ablation market is further classified into five application segments, namely liver cancer, lung cancer, kidney cancer, bone metastasis, and others (includes cancer of prostate, breast, colorectal, neuroendocrine, head, neck, and lumbar vertebrae).

 

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=142550258

 

A number of factors such as growing geriatric population, coupled with an increasing population base of cancer patients, technological advancements in the ablation devices, increasing demand for minimally invasive cancer treatment procedures, growing awareness about benefits about ablation procedures over conventional therapeutic and surgical procedures, and rising number of hospitals and surgical centers are fuelling the growth of the global tumor ablation market. On the other hand, cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the market growth.

 

As of 2014, North America holds the largest share of the tumor ablation market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR during 2014 to 2019. A number of factors such as large patient population base, growing government support to increase public access for advanced therapeutic and surgical procedures, and strengthening healthcare infrastructure across the region are stimulating the growth of the tumor ablation market in the Asia-Pacific region. AngioDynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Covidien, Plc (Ireland), Galil medical, Inc. (U.S.), HealthTronics, Inc. (U.S.), Mermaid Medical (Italy), Medtronic, Inc. (U.S.), CONMED Corporation (U.S.), Olympus Corporation (Japan), and Smith & Nephews Plc (U.K.) are the major players in the global tumor ablation market.

 

You can speak To Research Analyst to know more about Report:

http://www.marketsandmarkets.com/speaktoanalyst.asp?id=142550258

 

Browse Related Reports:

 

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019

http://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html

 

Electrophysiology Market - by Product [Diagnostic Catheter (Conventional, Advanced), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ICE)] & Application (Treatment & Monitoring Devices) - Global Forecasts To 2019

http://www.marketsandmarkets.com/Market-Reports/electrophysiology-market-200003281.html

 

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

 

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

 

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

 

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

 

Contact:
Mr. Rohan

North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets